Immunotherapy drug effective for metastatic triple negative breast … – Science Daily
Medical Daily |
Immunotherapy drug effective for metastatic triple negative breast …
Science Daily The immunotherapy drug, Pembrolizumab, is effective in shrinking tumors among metastatic triple negative breast cancer patients as found in a clinical trial. Treatment For Triple Negative Breast Cancer; Immunotherapy Drug Effective In New Trials |
